Inactive Instrument

Insiders China Biotech Services Holdings Limited Hong Kong S.E.

Equities

8037

BMG7713H1575

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

China Biotech Services Holdings Limited Announces Retirement of Ho Ivan Chun Kit as Independent Non-Executive Director	05-13	CI
China Biotech Services Holdings Limited Announces Redesignation of Chui Hoi Yam from an Executive Director to Non-Executive Director	30/06/23	CI
China Biotech Services Holdings Limited Announces Board Changes	05/12/22	CI
China Biotech Services Holdings Limited Announces Management Changes	20/06/22	CI
China Biotech Services Holdings Limited Announces Resignation of Yao Michael Yi Has Tendered as Co-Chairman and an Executive Director	20/05/21	CI
China Biotech Services Holdings Limited Announces Management Changes	18/05/21	CI
China Biotech Services Holdings Limited Announces Executive Changes	15/04/21	CI
China Biotech Services Holdings Limited Announces Shanghai Longyao Receives the Approval Letter for Clinical Trial from the National Medical Products Administration for the Company's Product Named Ly007 Cellular Injection	21/01/21	CI
China Biotech Services Holdings Limited Announces Re-Designation of Director and Appointment of Chief Technical Officer	16/12/19	CI
China Biotech Services Holdings Limited Appoints Yao Michael Yi as an Executive Director and Co-Chairman of the Board	20/05/19	CI
China Biotech Services Holdings Limited Announces Board Changes	31/12/18	CI
China Biotech Services Holdings Limited Appoints He Xun as an Executive Director	07/08/18	CI
China Biotech Services Holdings Limited Appoints Mr. Qian Hongji as an Independent Non-Executive Director and a Member of the Audit Committee	02/03/18	CI
China Biotech Services Holdings Limited Announces Resignation of Leung Ka Fai as Independent Non-Executive Director and Member of the Audit Committee of the Company	05/12/17	CI
Rui Kang Pharmaceutical Group Investments Limited has Changed its Name to China Biotech Services Holdings Limited	23/10/17	CI
Rui Kang Pharmaceutical Group Investments Limited Announces Management Changes	09/10/17	CI
Rui Kang Pharmaceutical Group Investments Limited Appoints Mr. Huang Song as Non-Executive Director	15/09/17	CI
Rui Kang Pharmaceutical Group Investments Limited Announces Executive Changes	28/08/17	CI
Rui Kang Pharmaceutical Group Investments Limited Announces Board Changes	07/08/17	CI
Rui Kang Pharmaceutical Group Investments Limited Announces Board Changes	04/08/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders China Biotech Services Holdings Limited Hong Kong S.E.

Equities

8037

BMG7713H1575

Insiders

Filters